Triterpenoid Modulators of Inflammatory Driven Carcinogenesis
炎症驱动的致癌作用的三萜调节剂
基本信息
- 批准号:8083600
- 负责人:
- 金额:$ 30.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-03-01 至 2015-12-31
- 项目状态:已结题
- 来源:
- 关键词:2-cyano-3,12-dioxoolean-1,9-dien-28-oic acidAnalgesicsAnti-Inflammatory AgentsAnti-inflammatoryAsiansAzoxymethaneBackBiologicalBiological FactorsCardiovascular systemCategoriesCellsChemicalsChemistryChemopreventionChemopreventive AgentChronicClinicalClinical ResearchColon CarcinomaColorectal CancerCommunicationCouplesCyclizationDNA Sequence RearrangementDiseaseDissectionEffectivenessEnzymesEpidemiologyEpigenetic ProcessEpithelialEpithelial CellsEpitheliumEventFVB MouseGastrointestinal tract structureGenesHumanImmuneImmune Cell ActivationIn VitroInflammationInflammation MediatorsInflammatoryLeadLinkLymphocyteMADH4 geneMalignant NeoplasmsMalignant neoplasm of cervix uteriMalignant neoplasm of gastrointestinal tractMediatingMedicineModelingMolecularMusNerve DegenerationNon-Steroidal Anti-Inflammatory AgentsOleanolic AcidOncogenicOrganic SynthesisPathway interactionsPhasePhysiologyPlantsPre-Clinical ModelPredispositionPreventionProductionPropertyResearch PersonnelSeriesSignal TransductionSkeletonSourceStressStructure-Activity RelationshipSystemT-LymphocyteTestingTraditional MedicineTumor Suppressor ProteinsWorkXenograft procedureantimicrobialcancer preventioncarcinogenesiscyclooxygenase 2cytokinegastrointestinalhuman NOS2A proteinin vitro Assayin vivoinnovationinterestmacrophagemouse modelnoveloleananeresponsescaffoldskeletaltumor
项目摘要
DESCRIPTION (provided by applicant): An extensive body of work supports a fundamental link between inflammation and a number of diseases, particularly cancer. Synthetic oleanane triterpenoids have been shown in preclinical models to be potent in the prevention of cancer driven by chronic inflammation. A central premise of the proposed work is that the oleanane triterpenoids are representative of a much larger class of anti-inflammatory/anti-cancer triterpenoids. We hypothesize that exploration of diverse triterpenoids, will allow a careful dissection of the molecular pathways behind triterpenoid chemoprevention, and will define novel classes of potent and effective cancer chemopreventive agents. To study the chemical space around the triterpenoids we will use two approaches including: 1) a novel oxidative cleavage and skeletal rearrangement; and 2) an innovative natural product isolation strategy to identify novel triterpenoids. These molecules will then be evaluated in vitro for their ability to suppress expression of key inflammatory mediators, and in vivo for their ability to suppress progression of gastrointestinal carcinogenesis in a system that couples immune mediated induction of oncogenic signaling intermediates with loss of expression of important tumor suppressor pathways.
PUBLIC HEALTH RELEVANCE: This project represents a collaborative endeavor between a two investigators interested in triterpenoids as cancer chemopreventives. The described aims will synthesize and isolate known and novel triterpenoids from traditional medicine sources to be tested as chemopreventives in inflammation driven models of carcinogenesis.
描述(由申请人提供):广泛的工作支持炎症与多种疾病,尤其是癌症之间的基本联系。在临床前模型中已显示合成的三萜类化合物三萜类化合物在预防慢性炎症驱动的癌症方面有效。拟议的工作的一个中心前提是,三萜的三萜类化合物代表了更大类别的抗炎/抗癌三萜类化合物。我们假设探索各种三萜类化合物,将仔细解剖三萜类化学预防后的分子途径,并将定义新型有效且有效的癌症化学预防剂的新型类型。为了研究三萜周围的化学空间,我们将使用两种方法,包括:1)一种新型的氧化裂解和骨骼重排; 2)一种创新的天然产品隔离策略,以识别新型三萜。然后,将在体外评估这些分子,以抑制关键炎症介质表达的能力,并在体内抑制抑制胃肠道致癌的进展的能力,该系统结合了免疫介导的致癌信号诱导的诱导与重要肿瘤抑制途径的表达的诱导致癌信号中间体。
公共卫生相关性:该项目代表了两个对三烯型兴趣作为癌症化学预防的研究者之间的合作努力。所描述的目的将从传统的医学来源中合成并分离已知和新颖的三萜类化合物,以在炎症驱动的癌变模型中被测试为化学预防剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory P Tochtrop其他文献
Gregory P Tochtrop的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory P Tochtrop', 18)}}的其他基金
Triterpenoid Modulators of Inflammatory Driven Carcinogenesis
炎症驱动的致癌作用的三萜调节剂
- 批准号:
8403947 - 财政年份:2011
- 资助金额:
$ 30.02万 - 项目类别:
Triterpenoid Modulators of Inflammatory Driven Carcinogenesis
炎症驱动的致癌作用的三萜调节剂
- 批准号:
8596802 - 财政年份:2011
- 资助金额:
$ 30.02万 - 项目类别:
Chemical Approaches to the Study of Cell Division
研究细胞分裂的化学方法
- 批准号:
6649050 - 财政年份:2003
- 资助金额:
$ 30.02万 - 项目类别:
Chemical Approaches to the Study of Cell Division
研究细胞分裂的化学方法
- 批准号:
6735628 - 财政年份:2003
- 资助金额:
$ 30.02万 - 项目类别:
Chemical Approaches to the Study of Cell Division
研究细胞分裂的化学方法
- 批准号:
6868209 - 财政年份:2003
- 资助金额:
$ 30.02万 - 项目类别:
相似国自然基金
芳基氨甲基-哌啶/四氢萘类μ/δ阿片受体双重功效镇痛分子成药性研究
- 批准号:81773635
- 批准年份:2017
- 资助金额:48.0 万元
- 项目类别:面上项目
长效阿片类镇痛药物镇痛与依赖分离的机制研究
- 批准号:81402911
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
运用代谢组学技术系统研究乌头碱类镇痛药的体内活性/毒性代谢产物
- 批准号:81302844
- 批准年份:2013
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
δ、μ、κ 阿片受体三重激动剂的作用机制研究
- 批准号:81173029
- 批准年份:2011
- 资助金额:14.0 万元
- 项目类别:面上项目
去甲肾上腺素α2A受体的镇痛调节新靶点- - -CSK
- 批准号:81072626
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
相似海外基金
PUFA metabolism for prevention and treatment of TMD pain: an interdisciplinary, translational approach.
PUFA 代谢预防和治疗 TMD 疼痛:一种跨学科的转化方法。
- 批准号:
10820840 - 财政年份:2023
- 资助金额:
$ 30.02万 - 项目类别:
Developing multitarget enzyme inhibitors as safe and effective anti-migraine treatments
开发多靶点酶抑制剂作为安全有效的抗偏头痛治疗方法
- 批准号:
10714658 - 财政年份:2023
- 资助金额:
$ 30.02万 - 项目类别:
Intra-Articular Drug Delivery Modulating Immune Cells in Inflammatory Joint Disease
关节内药物递送调节炎症性关节疾病中的免疫细胞
- 批准号:
10856753 - 财政年份:2023
- 资助金额:
$ 30.02万 - 项目类别:
A Novel Assay to Improve Translation in Analgesic Drug Development
改善镇痛药物开发转化的新方法
- 批准号:
10726834 - 财政年份:2023
- 资助金额:
$ 30.02万 - 项目类别:
Clinical Phase I trials on an IND single molecule dual inhibitor of Cav3 channels and soluble epoxide hydrolase for treatment of neuropathic pain
Cav3通道和可溶性环氧化物水解酶的单分子双重抑制剂治疗神经性疼痛的IND临床I期试验
- 批准号:
10760089 - 财政年份:2023
- 资助金额:
$ 30.02万 - 项目类别: